Kabra Drugs Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced net loss was INR 0.006 million compared to INR 0.01 million a year ago. For the nine months, net loss was INR 0.412 million compared to INR 0.487 million a year ago. Basic loss per share from continuing operations was INR 0.09 compared to INR 0.11 a year ago.